In search of value $CRBU
A look at the valuation of $CRBU.
A look at the valuation of $CRBU.
Cash = $326 million
This first program has some best in class data so far in CD19 cancers. This indication could do about $500 million a year.
*.5 for some phase 1 data
= $250 million value
This first program has some best in class data so far in CD19 cancers. This indication could do about $500 million a year.
*.5 for some phase 1 data
= $250 million value
Their second program is for BCMA in Multiple Myeloma. I think this could also do $500 million a year in sales.
*.1 for preclinical
= $50 million value
*.1 for preclinical
= $50 million value
All in, I get to $626 million valuation. They have about 61 million shares outstanding. That comes to $10.26 which makes it about -13% under valued.
Loading suggestions...